World Drug Sales Up 8% In Jan-Nov 1995

5 February 1996

Drug purchases through retail pharmacies in the world's leading 10 markets rose 8% in the first 11 months of 1995 to $125.68 million, reports IMS International.

The fastest-growing country was Spain, rising 11% to $4.35 billion, then the USA, up 10% to $48.90 billion, and Japan and the UK, rising 9% to $24.01 billion and $5.70 billion respectively. By therapeutic category, the largest increase was for respiratory products, up 13% to $12.62 billion, followed by central nervous system drugs, anti-infectives and blood agents, all up 12% to $16.24 billion, $13.08 billion and $7.07 billion respectively.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight